Replies to post #233271 on Biotech Values

[DewDiligence]

INVA acquires LJPC for $6.23/sh cash—an 84% premium to Friday’s close:

https://www.businesswire.com/news/home/20220711005314/en

The nominal deal value is $149M.

INVA is a “roll-up” company that buys distressed biotech assets.